Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23396339 | 0.98 | ALDH1A1 (0.43) | ALDH1A1MAOB | |
| SCHEMBL13656252 | 0.93 | KDM4E (0.38) | ALDH1A1MAOB | |
| SCHEMBL823834 | 0.83 | MEN1 (0.41) | SIGMAR1 | |
| SCHEMBL26004844 | 0.83 | KDM4E (0.32) | ALDH1A1 | |
| SCHEMBL23396341 | 0.80 | KDM5A (0.33) | — | |
| SCHEMBL12380889 | 0.78 | CHRM2 (0.33) | — | |
| SCHEMBL26003910 | 0.78 | MEN1 (0.31) | — | |
| SCHEMBL13801838 | 0.77 | FDPS (0.35) | — | |
| SCHEMBL10932413 | 0.77 | MAPK1 (0.36) | ALDH1A1 | |
| SCHEMBL13759742 | 0.76 | ALDH1A1 (0.48) | ALDH1A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11013696-B2 | Lipids and lipid compositions for the delivery of active agents | NOVARTIS AG (CH) | 2021-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11013696-B2 | Lipids and lipid compositions for the delivery of active agents | PHOSPHO1, SGMS1, LIPA | ALDH1A1 1564/4885SIGMAR1 628/4885MAOB 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.